Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Monday broker round-up

Mon, 18th Nov 2019 13:24
(Sharecast News) - Croda International: Liberum Capital downgrades to hold with a target price of 4,400p.

Cranswick: Peel Hunt reiterates hold with a target price of 2,900p.

Persimmon: Peel Hunt reiterates hold with a target price of 2,025p.

Energean Oil: Peel Hunt reiterates buy with a target price of 1,205p.

BT Group: Barclays downgrades to underweight with a target price of 160p.

Sage: Shore Capital Markets downgrades to hold.

Consort Medical: Shore Capital Markets downgrades to hold with a target price of 930p.

Civitas Social Housing: Liberum initiates at buy with a target price of 104p.

Burberry: UBS reiterates neutral with a target price of 2,175p.

Howden Joinery Group: UBS reiterates neutral with a target price of 640p.

HSBC: Jefferies upgrades to buy with a target price of 790p.

SSE: JP Morgan reiterates neutral with a target price of 1,250p.

Related News

LONDON MARKET CLOSE: Segro bid boosts FTSE 100 as gold and oil sink
1 hour ago

LONDON MARKET CLOSE: Segro bid boosts FTSE 100 as gold and oil sink

(Alliance News) - The FTSE 100 closed higher on Wednesday as gains in property stocks and housebuilders offset a slump in mining stocks as metals pric...

LONDON BROKER RATINGS: Berenberg says buy NatWest, hold Lloyds
9 hours ago

LONDON BROKER RATINGS: Berenberg says buy NatWest, hold Lloyds

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

PRESS: BT pension scheme takes GBP300 million hit on Thames Water - FT
9 hours ago

PRESS: BT pension scheme takes GBP300 million hit on Thames Water - FT

(Alliance News) - BT Group PLC's pension scheme lost GBP300 million after writing off its stake in Thames Water, the Financial Times reported on Wedne...

CSRT.L News

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
17 Feb 2020

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Monday broker round-up
10 Feb 2020

Monday broker round-up

(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
4 Feb 2020

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm To Make No Further Changes To Consort Medical Offer
29 Jan 2020

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm Extends Consort Medical Offer Deadline To February 4
24 Jan 2020

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Buys 10% Of Takeover Target Consort Medical
22 Jan 2020

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
14 Jan 2020

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Friday broker round-up
10 Jan 2020

Friday broker round-up

(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.